2019
DOI: 10.1111/jep.13256
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative analgesia with parecoxib sodium improves postoperative pain and immune function in patients undergoing hepatectomy for hepatocellular carcinoma

Abstract: Rationale, aims, and objectives: Acute postoperative pain can result in immune dysfunction, which can be partly mitigated by efficient pain management. Opioids that have been widely applied to analgesia have been shown to suppress immune function, which has a negative impact on the treatment of patients with cancer. This study investigated the effects of perioperative fentanyl analgesia alone or in combination with parecoxib sodium on postoperative pain, immune function, and prognosis in patients undergoing he… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
16
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 29 publications
(26 reference statements)
0
16
0
Order By: Relevance
“…Parecoxib is the most commonly used selective COX-2 inhibitor in the clinic, and is the only parenterally administered coxib available to date [ 10 , 11 ]. It has been reported that parecoxib could improve the postoperative analgesic effect and immune function when used for multimodal analgesia, and further postpone postoperative cancer recurrence [ 12 , 13 ]. Other studies have reported that parecoxib shows antitumor effects against human osteosarcoma, glioblastoma, and intestinal cancers [ 14 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…Parecoxib is the most commonly used selective COX-2 inhibitor in the clinic, and is the only parenterally administered coxib available to date [ 10 , 11 ]. It has been reported that parecoxib could improve the postoperative analgesic effect and immune function when used for multimodal analgesia, and further postpone postoperative cancer recurrence [ 12 , 13 ]. Other studies have reported that parecoxib shows antitumor effects against human osteosarcoma, glioblastoma, and intestinal cancers [ 14 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…When compared to the placebo, the use of NSAIDs proved to be more effective in pain control and associated with a higher opioid-sparing effect. These studies also suggest that NSAID use is possibly associated with a more preserved immune function (by increasing CD3+ and NK cell levels), reduced systemic inflammatory response (decreased levels of IL-4 and increased TGF-β), associated with a longer tumor-free interval and disease-free survival time (Table 3) [40,45]. The use of parecoxib or ketorolac leads to similar results in terms of postoperative pain control (Table 3) [55].…”
Section: Trials Assessing Nsaidsmentioning
confidence: 86%
“…The role of NSAIDs in preventing postoperative pain after open liver surgery was evaluated in three studies, which included a total of 186 patients: two compared to placebo (RCTs) and one compared parecoxib to ketorolac (RO) [40,45,55]. When compared to the placebo, the use of NSAIDs proved to be more effective in pain control and associated with a higher opioid-sparing effect.…”
Section: Trials Assessing Nsaidsmentioning
confidence: 99%
“…In immunosuppressive organisms, the growth of immune organs, including the thymus and spleen, is inhibited, and the levels of natural killer (NK) cells and immunoglobulin in the serum decrease [4]. In addition, the level of CD3/CD4 lymphocytes also decreased due to immunosuppression [5]. RAW264.7 cells, one of the macrophages, play an important role in the innate immune system.…”
Section: Introductionmentioning
confidence: 99%